| Financial Year |
March 31 2023 |
| Monetary Funds |
1,828,227,991.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,609,021.54 |
| Accounts Receivable |
1,564,719,387.54 |
| Advances to Suppliers |
79,140,553.72 |
| Other Receivables |
33,444,807.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,407,799,460.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,682,524.63 |
| Total Current Assets |
5,331,388,070.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
255,696,793.29 |
| Investment Properties |
1,868,238.70 |
| Fixed Assetes |
1,522,207,909.87 |
| Under-construction Projects |
714,139,160.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
306,503,744.04 |
| R&D expenses |
9,563,593.67 |
| Goodwill |
35,106,987.48 |
| Long-Term Deferred and Prepaid Expenses |
28,870,964.30 |
| Deferred Income Tax Assets |
31,176,551.96 |
| Other Non-Current Assets |
12,427,627.15 |
| Sub-Total of Non-Current Assets |
3,261,355,231.21 |
| Total Assets |
8,592,743,301.89 |
| Short-Term Loans |
1,398,856,341.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
189,397,116.12 |
| Accounts Payable |
798,580,248.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,433,404.54 |
| Taxes Payable |
56,479,168.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,070,656.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,809,585.26 |
| Other Current Liabilities |
24,571,030.35 |
| Sub-Total of Current Liabilities |
2,827,856,227.65 |
| Long-term Loans |
330,000,000.00 |
| Bonds Payable |
1,307,077,724.64 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
509,912.43 |
| Other Non-Current Liabilities |
148,950,000.00 |
| Sub-Total of Non-Current Liabilities |
1,976,057,657.60 |
| Total Liabilities |
4,803,913,885.25 |
| Paid-In Capital(Or Share Stock) |
278,144,604.00 |
| Capital Surplus |
1,932,989,452.59 |
| Surplus Reserve |
120,219,110.06 |
| LESS:Treasury Stock |
199,631,260.98 |
| Undistributed Profits |
1,157,231,001.52 |
| Minority Stockholder's Interest |
293,296,220.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,495,533,196.64 |
| Owner's Equity（Stockholder's Equity） |
3,788,829,416.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,592,743,301.89 |
